New Key Statistics Module, Z-Score and F-Score
NAS:PCRX Key Ratios
| Market Cap $ M | 1,224.95 |
| Enterprise Value $ M | 1,532.42 |
| P/E(ttm) | 31.72 |
| PE Ratio without NRI | 12.74 |
| Forward PE Ratio | 9.58 |
| Price/Book | 1.41 |
| Price/Sales | 2.10 |
| Price/Free Cash Flow | 10.55 |
| Price/Owner Earnings | 28.13 |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 674.00 |
| EPS (TTM) $ | 0.83 |
| Beneish M-Score | -2.67 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 38.00 |
| y-y EBITDA Growth Rate % | -1.40 |
| EV-to-EBIT | 19.39 |
| EV-to-EBITDA | 9.91 |
| PEG | 0.34 |
| Shares Outstanding M | 46.52 |
| Net Margin (%) | 6.22 |
| Operating Margin % | 12.94 |
| Pre-tax Margin (%) | 9.14 |
| Quick Ratio | 4.17 |
| Current Ratio | 5.24 |
| ROA % (ttm) | 2.67 |
| ROE % (ttm) | 5.18 |
| ROIC % (ttm) | 4.72 |
| Dividend Yield % | -- |
| Altman Z-Score | 1.86 |
PCRX Number of Guru Trades
PCRX Volume of Guru Trades
Gurus Latest Trades with NAS:PCRX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:PCRX is held by these investors
Total 3
Pacira BioSciences Inc Insider Transactions
No Available Data
News about NAS:PCRX
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers